Price cap on concentrators, five other medical devices extended

New Delhi: The Nationwide Pharmaceutical Pricing Authority (NPPA) has prolonged the capping of the commerce margin of oxygen concentrators and 5 different medical units which it had imposed within the 12 months 2021.

In a latest assembly held within the NPPA, the drug pricing regulator “deliberated upon the matter and directed that the MRPs of 5 medical units specifically pulse oximeter, blood strain monitoring machine, nebulizer, digital thermometer, glucometer shall proceed to be monitored as per para 20(1) of DPCO 2013,” mentioned the minutes of the assembly.

To make sure its uninterrupted availability, worth regulation was launched throughout Covid-19 pandemic. The TMR was earlier prolonged in March 2023 because it was expiring in March contemplating that the virus continues to be a risk for the general public well being within the nation. The worth rules have been prolonged until June 30, 2023 or until additional order, whichever is earlier.

Nonetheless, in a gathering held on June 19, the NPPA determined to increase it additional.

The TMR for oxygen concentrators was introduced in June, 2021. In keeping with the federal government notification it had put a cap at 70% on the commerce margin of oxygen concentrators on the first level of sale.